HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs.

Abstract
We present data providing new evidence that poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA)-bound drugs, unlike free drugs, have both cytostatic and immunomobilizing activity (CIA). Immediately after injection, due to the high level of the drug, the main activity of the polymeric conjugate is cytotoxic and cytostatic. Later on, long-term circulating PHPMA-bound drug, at concentrations lower than its minimal inhibitory levels, mobilizes the defense mechanisms of the host. Cytotoxic and cytostatic effects of drug-PHPMA were repeatedly confirmed. The following data support the concept of the immunomobilizing activity of the N-(2-hydroxypropyl)methacrylamide (HPMA) conjugates: (a) pre-treatment with free drugs (doxorubicin, cyclosporin A) accelerates the appearance of EL4 mouse T-cell lymphoma while a similar pre-treatment with doxorubicin-PHPMA induces limited but definitive mobilization of the host's defense mechanisms; (b) mice cured of EL4 mouse T-cell lymphoma, BCL1 mouse B-cell leukemia and 38C13 mouse B-cell lymphoma by injection of doxorubicin-PHPMA conjugate targeted with monoclonal antibodies (anti-Thy 1.2 for EL4, anti-B1 for BCL1 and anti-CD71 for 38C13) and re-transplanted with a lethal dose of the same cancer cells survive without any treatment considerably longer than control mice; (c) increased NK activity and anti-cancer antibody was detected only in animals treated with doxorubicin-PHPMA conjugate; and (d) considerably increased NK and LAK activity was seen in a human patient treated for generalized breast carcinoma with doxorubicin-PHPMA-IgG.
AuthorsB Ríhová, J Strohalm, K Kubácková, M Jelínková, O Hovorka, M Kovár, D Plocová, M Sírová, M St'astný, L Rozprimová, K Ulbrich
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 78 Issue 1-3 Pg. 97-114 (Jan 17 2002) ISSN: 0168-3659 [Print] Netherlands
PMID11772452 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Methacrylates
  • Doxorubicin
  • hydroxypropyl methacrylate
Topics
  • Animals
  • Antibody-Dependent Cell Cytotoxicity
  • Antineoplastic Agents (administration & dosage)
  • Breast Neoplasms (drug therapy)
  • Doxorubicin (administration & dosage)
  • Drug Delivery Systems
  • Hemangiosarcoma (drug therapy, immunology)
  • Killer Cells, Natural (immunology)
  • Methacrylates (administration & dosage)
  • Mice
  • Neoplasms, Experimental (drug therapy, immunology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: